Alongside margin recovery, Biocon Biologics has also gained market share, with oncology remaining a key focus area.

Tambe said the company, a subsidiary of the Bengaluru-based Biocon Ltd, has five products in the pipeline for launch in the ...

US biotech major Amgen =announced that it has reached resolution of its patent infringement litigation related to South Korea ...

January saw almost every major cardiovascular subspecialty represented among our most-clicked stories of the month.

On January 23, 2025, the District Court for the District of New Jersey entered a Consent Judgment and Injunction in view of a ...

As Sandoz gears up to launch one of the most anticipated biosimilars of the year, the company could face near-term ...

Teva Pharmaceutical Industries TEVA reported fourth-quarter 2024 adjusted earnings of 71 cents per share, which beat the ...

Dr. Reddy's Lab is poised to witness crosswinds from a drop in revenue from the patent expiration of Revlimid and increased ...

Dr Reddy's Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after ...

National Nutrition and Health Survey revealed a startling statistic: nearly 80 percent of Filipino women and 60 percent of ...

Q3 2025 Earnings Call Transcript January 23, 2025 Operator: Ladies and gentlemen, good day and welcome to the Quarter Three ...

Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...